Morphosys Ag (MOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MOR Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Morphosys Ag manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
0 0 0 (Dec 31 2022)
Assets
Cash And Cash Equivalents175.33
Cash & Short-term Investments175.00
Accounts receivable35.50
Inventories69.52
Inventories68.66
Other Current Assets664.67
Total Current Assets900.47
Equipment/Property/Plant Net4.30
Goodwill net378.65
Intangible Assets933.75
Other Assets, Noncurrent970.04
Total Assets2,241.51
Liabilities
Short-term Debt271.75
Other Liabilities, Current22.72
Total Current Liabilities292.38
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent7.25
Noncurrent Provisions1,918.51
Total Liabilities2,187.25
Stockholders' Equity
Other Equity54.94
Common Stockholder's Equity54.94
Total Stockholder's Equity54.26
Liabilities & Stockholder's Equity2,241.51
4 historic quarters locked

Sign in to unlock the full Morphosys Ag balance sheet history.

About Morphosys Ag Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20231231)
  • Filed with the SEC: March 13, 2024
  • Source: mor-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-010887

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI